# DexCom acquires TypeZero Technologies

DexCom announced the acquisition of TypeZero Technologies, a developer of algorithms for automated insulin delivery systems. Terms were not disclosed. DexCom expects to support the first commercial launch of an AID system using TypeZero's algorithm in 2019.

- Type: Acquisition
- Announced: 2018-08-27
- Where: United States
- Status: announced
- Products: insulin dosing algorithm
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DexCom](https://endata.com/companies/6670.md) (acquirer)
- [TypeZero Technologies](https://endata.com/companies/33954.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/dexcom-acquires-maker-of-insulin-dosing-algorithm/530960/), 2018-08-27: "DexCom announced last week the acquisition of TypeZero Technologies, a developer of algorithms that manage automated insulin delivery (AID) for people with diabetes."
- [cvilletomorrow.org](https://www.cvilletomorrow.org/dexcom-acquires-typezero-technologies/), 2018-08-28: "TypeZero is a great fit for Dexcom as we look to deliver a growing set of tools to both our insulin delivery partners and our customers."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.